Technology and automation within patient assistance programs can enhance the patient journey and assist pharmaceutical manufacturers at a lower cost, explained Josh Marsh, vice president of Sonexus at Cardinal Health.
Josh Marsh, vice president of Sonexus at Cardinal Health, says that innovations like technology and automation within patient assistance programs can help both patients and manufacturers.
Transcript
How have patient assistance programs in the pharmaceutical industry evolved in recent years?
I've definitely seen a shift over the past 5 to 7 years as a specialty space has grown; more products being launched, more of the patient population being positively impacted by these products coming to the market. I always say that historically, when a brand grew 10%, your patient service program added 10% of new FTEs [full-time equivalents] to the program to support it. Well, that gets very expensive as your brand grows in the market. So, what we've seen is by being able to implement more technology, more automation into the process, we can not only positively impact the patient journey, decreasing that turnaround time, but we're also able to do more for our manufacturers at a lower cost, which is always a goal as well.
Ruxolitinib Cream Shows Long-Term Safety in AD, Potential for PN Treatment
March 8th 2025Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream (Opzelura; Incyte) in atopic dermatitis (AD), while late-breaking research highlighted its potential efficacy in prurigo nodularis (PN).
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Shaping Dermatology's Future by Increasing Access, Data, and Advocacy
March 7th 2025Thy N. Huynh, MD, FAAD, Bruce A. Brod, MHCI, MD, FAAD, and Melissa Piliang, MD, FAAD, discussed expanding access to pediatric dermatology, dermatology data aggregation, and advocacy for Medicare physician payment reform, respectively.
Read More